Virgin Galactic Holdings, Inc 8-K, filed May 10, 2021
Virgin Galactic Holdings, Inc (SPCE)
8-K
2021-05-10
For: 2021-05-10
View Original
Added on
April 08, 2026
About this 8-K
Virgin Galactic Holdings, Inc filed this 8-K on May 10, 2021.
Items reported
- Item 2.02: Financial results
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 8-K
____________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 10, 2021
____________________________
(Exact name of registrant as specified in its charter)
____________________________
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
(575 ) 424-2100
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | |||||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On May 10, 2021, Virgin Galactic Holdings, Inc. (the “Company”) issued a press release announcing certain financial and other results for the fiscal quarter ended March 31, 2021. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this “Current Report”) and is incorporated herein by reference.
The information furnished in this Current Report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Virgin Galactic Holdings, Inc. | ||||||||||||||
| Date: May 10, 2021 | By: | /s/ Michael Colglazier | ||||||||||||
| Name: | Michael Colglazier | |||||||||||||
| Title: | Chief Executive Officer, President and Director | |||||||||||||
Exhibit 99.1
Virgin Galactic Announces First Quarter 2021 Financial Results
LAS CRUCES, N.M. – May 10, 2021 – Virgin Galactic Holdings, Inc. (NYSE: SPCE) (“Virgin Galactic” or the "Company”), a vertically integrated aerospace and space travel company, today announced its financial results for the first quarter ended March 31, 2021.
"We continue to make strides towards our strategic objectives and have solid momentum as we focus on completing our flight test program,” said Michael Colglazier, Chief Executive Officer of Virgin Galactic. “We are committed to delivering one of the world's most unique and transformational customer experiences, with safety at the core of everything we do. Our greatest asset is our incredibly talented group of employees, and the strength of the leadership team we have assembled for the next phase of our journey."
First Quarter 2021 Business Highlights:
•Unveiled VSS Imagine, the first SpaceShip III class vehicle in Virgin Galactic’s growing fleet, on March 30, 2021.
• Total Future Astronauts remained at approximately 600, as of March 31, 2021.
• Continue to build senior management team:
◦ Appointed Doug Ahrens as Chief Financial Officer, effective March 1, 2021.
◦ Appointed Swami Iyer as President of Aerospace Systems, effective March 22, 2021.
◦ Appointed Stephen Justice as Vice President of Engineering, effective March 1, 2021.
•Established and launched the Virgin Galactic Space Advisory Board, composed of leading experts from the aerospace sector.
•Announced a three-year extension to the global Land Rover partnership.
First Quarter 2021 Financial Highlights:
•Cash position remains strong, with cash and cash equivalents of $617 million as of March 31, 2021.
•Net loss of $130 million, compared to a $377 million net loss in the first quarter of 2020.
•GAAP selling, general, and administrative expenses of $45 million, compared to $27 million in the first quarter of 2020. Non-GAAP selling, general and administrative expenses of $27 million in the first quarter of 2021, compared to $23 million in the first quarter of 2020.
•GAAP research and development expenses of $36 million, compared to $34 million in the first quarter of 2020. Non-GAAP research and development expenses of $32 million in the first quarter of 2020, compared to $33 million in the first quarter of 2020.
•Adjusted EBITDA totaled $(56) million, compared to $(53) million in the first quarter of 2020.
•Cash paid for capital expenditures totaled $1 million, compared to $4 million in the first quarter of 2020.
Recent Updates:
•Completed corrective EMI work on VSS Unity such that the spaceship is ready to start pre-flight procedures for flight
•Timing of next flight test in 2021 is currently being re-evaluated
COVID-19 Impact
The Company is continuing to experience ongoing delays to its business and operations due to COVID-19. The Company continues to operate under strict protocols and follows rigorous health and safety procedures, in line with CDC, state and local guidelines, to ensure employee safety.
Conference Call Information
Virgin Galactic will host a conference call to discuss the results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) today. To access the conference call, parties should dial (833) 968-2325 and enter the conference ID number 2488377. The live audio webcast along with supplemental information will be accessible on the Company’s Investor Relations website at investors.virgingalactic.com. A recording of the webcast will also be available following the conference call.
About Virgin Galactic Holdings
Virgin Galactic Holdings, Inc. is a vertically integrated aerospace and space travel company, pioneering human spaceflight for private individuals and researchers, as well as a manufacturer of advanced air and space vehicles. The Company is developing a spaceflight system designed to offer customers a unique and transformative experience. You can find more information at https://www.virgingalactic.com.
Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of federal securities laws with respect to Virgin Galactic Holdings, Inc. (the "Company"), including statements regarding the Company’s spaceflight systems, markets and expected flight schedule. These forward-looking statements generally are identified by words such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the factors, risks and uncertainties included in Amendment No. 2 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as such factors may be updated from time to time in our other filings with the Securities and Exchange Commission (the "SEC"), accessible on the SEC’s website at www.sec.gov and the Investor Relations section of our website at www.virgingalactic.com. These filings identify and address other important risks and uncertainties that could cause the Company’s actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
First Quarter 2021 Financial Results
VIRGIN GALACTIC HOLDINGS, INC.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited and in thousands except for per share data)
| Three Months Ended | ||||||||||||||
| March 31, 2021 | March 31, 2020 | |||||||||||||
| (As restated) | ||||||||||||||
| Revenue | $ | — | $ | 238 | ||||||||||
| Cost of revenue | — | 173 | ||||||||||||
| Gross profit | — | 65 | ||||||||||||
| Selling, general, and administrative expenses | 44,914 | 26,755 | ||||||||||||
| Research and development expenses | 36,363 | 34,282 | ||||||||||||
| Operating loss | (81,277) | (60,972) | ||||||||||||
| Change in fair value of warrants | (48,719) | (316,896) | ||||||||||||
| Interest income (expense), net | 318 | 1,168 | ||||||||||||
| Other income (expense), net | 27 | (172) | ||||||||||||
| Loss before income taxes | (129,651) | (376,872) | ||||||||||||
| Income tax benefit (expense) | (43) | 46 | ||||||||||||
| Net loss | (129,694) | (376,826) | ||||||||||||
| Other comprehensive loss: | ||||||||||||||
| Foreign currency translation adjustment | 27 | (54) | ||||||||||||
| Total comprehensive loss | $ | (129,667) | $ | (376,880) | ||||||||||
| Net loss per share: | ||||||||||||||
| Basic and diluted | $ | (0.55) | $ | (1.86) | ||||||||||
| Weighted-average shares outstanding: | ||||||||||||||
| Basic and diluted | 234,191,636 | 202,409,552 | ||||||||||||
VIRGIN GALACTIC HOLDINGS, INC.
Condensed Consolidated Balance Sheets
(In thousands, except share data)
| March 31, 2021 | December 31, 2020 | ||||||||||||||||||||||
| (Unaudited) | (As restated) | ||||||||||||||||||||||
| Assets | |||||||||||||||||||||||
| Current assets | |||||||||||||||||||||||
| Cash and cash equivalents | $ | 616,625 | $ | 665,924 | |||||||||||||||||||
| Restricted cash | 13,031 | 13,031 | |||||||||||||||||||||
| Inventories | 30,187 | 30,483 | |||||||||||||||||||||
| Prepaid expenses and other current assets | 14,486 | 18,489 | |||||||||||||||||||||
| Total current assets | 674,329 | 727,927 | |||||||||||||||||||||
| Property, plant, and equipment, net | 50,936 | 53,148 | |||||||||||||||||||||
| Other non-current assets | 22,762 | 22,915 | |||||||||||||||||||||
| Total assets | $ | 748,027 | $ | 803,990 | |||||||||||||||||||
| Liabilities and Stockholders' Equity | |||||||||||||||||||||||
| Current liabilities | |||||||||||||||||||||||
| Accounts payable | $ | 3,738 | $ | 5,998 | |||||||||||||||||||
| Accrued expenses | 28,351 | 22,982 | |||||||||||||||||||||
| Customer deposits | 83,015 | 83,211 | |||||||||||||||||||||
| Other current liabilities | 2,981 | 2,830 | |||||||||||||||||||||
| Total current liabilities | 118,085 | 115,021 | |||||||||||||||||||||
| Non-current liabilities | |||||||||||||||||||||||
| Warrant liability | 184,159 | 135,440 | |||||||||||||||||||||
| Other long-term liabilities | 25,939 | 26,451 | |||||||||||||||||||||
| Total liabilities | $ | 328,183 | $ | 276,912 | |||||||||||||||||||
| Stockholders' Equity | |||||||||||||||||||||||
Preferred stock, $0.0001 par value; 10,000,000 authorized; none issued and outstanding | $ | — | $ | — | |||||||||||||||||||
| Common stock, $0.0001 par value; 700,000,000 shares authorized; 237,274,430 and 236,123,659 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively | 23 | 23 | |||||||||||||||||||||
| Additional paid-in capital | 1,311,607 | 1,297,794 | |||||||||||||||||||||
| Accumulated deficit | (891,817) | (770,744) | |||||||||||||||||||||
| Accumulated other comprehensive income | 31 | 5 | |||||||||||||||||||||
| Total stockholders' equity | 419,844 | 527,078 | |||||||||||||||||||||
| Total liabilities and stockholders' equity | $ | 748,027 | $ | 803,990 | |||||||||||||||||||
VIRGIN GALACTIC HOLDINGS, INC.
Condensed Consolidated Statements of Cash Flows
(Unaudited and in thousands)
| Three Months Ended | ||||||||||||||||||||||||||
| March 31, 2021 | March 31, 2020 | |||||||||||||||||||||||||
| (As restated) | ||||||||||||||||||||||||||
| Cash flows from operating activities | ||||||||||||||||||||||||||
| Net loss | $ | (129,694) | $ | (376,826) | ||||||||||||||||||||||
| Stock-based compensation | 22,111 | 4,425 | ||||||||||||||||||||||||
| Depreciation and amortization | 2,869 | 2,105 | ||||||||||||||||||||||||
| Change in fair value of warrant liability | 48,719 | 316,896 | ||||||||||||||||||||||||
| Other operating activities, net | 10 | 1 | ||||||||||||||||||||||||
| Change in assets and liabilities | ||||||||||||||||||||||||||
| Inventories | 296 | (1,980) | ||||||||||||||||||||||||
| Other current and non-current assets | 3,692 | 2,142 | ||||||||||||||||||||||||
| Accounts payable and accrued expenses | 3,322 | (2,978) | ||||||||||||||||||||||||
| Customer deposits | (196) | (98) | ||||||||||||||||||||||||
| Other current and non-current liabilities | 102 | — | ||||||||||||||||||||||||
| Net cash used in operating activities | (48,769) | (56,313) | ||||||||||||||||||||||||
| Cash flows from investing activity | ||||||||||||||||||||||||||
| Capital expenditures | (819) | (4,036) | ||||||||||||||||||||||||
| Cash used in investing activity | (819) | (4,036) | ||||||||||||||||||||||||
| Cash flows from financing activities | ||||||||||||||||||||||||||
| Payments of finance lease obligations | (34) | (23) | ||||||||||||||||||||||||
| Proceeds from issuance of common stock pursuant to stock options exercised | 10,837 | — | ||||||||||||||||||||||||
| Transaction costs | — | (697) | ||||||||||||||||||||||||
| Withholding taxes paid on behalf of employees on net settled stock-based awards | (10,514) | — | ||||||||||||||||||||||||
| Net cash provided by (used in) by financing activities | 289 | (720) | ||||||||||||||||||||||||
| Net decrease in cash and cash equivalents | (49,299) | (61,069) | ||||||||||||||||||||||||
| Cash, cash equivalents and restricted cash at beginning of period | 678,955 | 492,721 | ||||||||||||||||||||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 629,656 | $ | 431,652 | ||||||||||||||||||||||
| Cash and cash equivalents | $ | 616,625 | $ | 419,374 | ||||||||||||||||||||||
| Restricted cash | 13,031 | 12,278 | ||||||||||||||||||||||||
| Cash, cash equivalents and restricted cash | $ | 629,656 | $ | 431,652 | ||||||||||||||||||||||
Use of Non-GAAP Financial Measures (Unaudited)
This press release references certain non-GAAP financial measures, including adjusted EBITDA, non-GAAP selling, general, and administrative expense and non-GAAP research and development expense. The Company defines adjusted EBITDA as earnings before interest expense, taxes, depreciation and amortization, stock-based compensation, and certain other items the Company believes are not indicative of its core operating performance. It defines non-GAAP selling, general, and administrative expenses as selling, general, and administrative expenses other than stock-based compensation and non-capitalized transaction costs, and non-GAAP research and development expenses as research and development expenses other than stock-based compensation. None of these non-GAAP financial measures is a substitute for or superior to measures of financial performance prepared in accordance with generally accepted accounting principles in the United States (GAAP) and should not be considered as an alternative to any other performance measures derived in accordance with GAAP.
The Company believes that presenting these non-GAAP financial measures provides useful supplemental information to investors about the Company in understanding and evaluating its operating results, enhancing the overall understanding of its past performance and future prospects, and allowing for greater transparency with respect to key financial metrics used by its management in financial and operational-decision making. However, there are a number of limitations related to the use of non-GAAP measures and their nearest GAAP equivalents. For example, other companies may calculate non-GAAP measures differently, or may use other measures to calculate their financial performance, and therefore any non-GAAP measures the Company uses may not be directly comparable to similarly titled measures of other companies.
A reconciliation of adjusted EBITDA to net loss for the three months ended March 31, 2021 and March 31, 2020 , respectively, are set forth below:
| Amounts in thousands ($) | Three Months Ended | |||||||||||||
| March 31, 2021 | March 31, 2020 | |||||||||||||
| Net Loss | (129,694) | (376,826) | ||||||||||||
| Income tax benefit (expense) | (43) | 46 | ||||||||||||
| Interest expense | 7 | 9 | ||||||||||||
| Depreciation & amortization | 2,869 | 2,105 | ||||||||||||
| Non-capitalized transaction costs* | — | 697 | ||||||||||||
| Stock-based compensation | 22,111 | 4,425 | ||||||||||||
| Change in fair value of warrants | 48,719 | 316,896 | ||||||||||||
| Adjusted EBITDA | (55,945) | (52,740) | ||||||||||||
A reconciliation of selling, general, and administrative expenses to non-GAAP selling, general, and administrative expenses for the three months ended March 31, 2021 and March 31, 2020, respectively, are set forth below:
| Amounts in thousands ($) | Three Months Ended | |||||||||||||
| March 31, 2021 | March 31, 2020 | |||||||||||||
| Selling, general, and administrative expenses | 44,914 | 26,755 | ||||||||||||
| Stock-based compensation | 18,038 | 2,870 | ||||||||||||
| Non-capitalized transaction costs* | — | 697 | ||||||||||||
| Non-GAAP selling, general, administration expenses | $ | 26,876 | $ | 23,188 | ||||||||||
A reconciliation of research and development expenses to non-GAAP research and development expenses for the three months ended March 31, 2021 and March 31, 2020, respectively, are set forth below:
| Amounts in thousands ($) | Three Months Ended | |||||||||||||
| March 31, 2021 | March 31, 2020 | |||||||||||||
| Research and development expenses | 36,363 | 34,282 | ||||||||||||
| Stock-based compensation | 4,074 | 1,555 | ||||||||||||
| Non-GAAP Research and development expenses | $ | 32,289 | $ | 32,727 | ||||||||||
_____________
*Non-capitalized transaction costs include non-recurring expenses related to preparation and filing of an S-1 registration statement in the first quarter of 2020.
For investor relations inquiries:
Seth Zaslow – Vice President, Investor Relations
seth.zaslow@virgingalactic.com
For media inquiries:
Aleanna Crane – Vice President, Communications
aleanna.crane@virgingalactic.com